Ferric Citrate Hydrate Has Little Impact on Hyperplasia of Enterochromaffin Cells in the Rat Small Intestine Compared to Sodium Ferrous Citrate
- PMID: 36007495
- PMCID: PMC9838135
- DOI: 10.1159/000525300
Ferric Citrate Hydrate Has Little Impact on Hyperplasia of Enterochromaffin Cells in the Rat Small Intestine Compared to Sodium Ferrous Citrate
Abstract
Introduction: The most detrimental factor preventing the use of oral iron in the treatment of iron deficiency anemia is gastrointestinal side effects accompanied by nausea and vomiting. Anorexia is a known secondary effect of nausea and vomiting. The important gastrointestinal signaling molecule 5-hydroxytryptamine (5-HT) is critically involved in not only physiological function but also nausea and vomiting. The present study was designed to compare the effects of the administration of sodium ferrous citrate (SF) and ferric citrate hydrate (FC) to rats on anorexia and hyperplasia of enterochromaffin cells, which mainly synthesize and store 5-HT.
Methods: Rats received either SF (3 or 30 mg/kg/day) or FC (30 mg/kg/day) orally for 4 days. Food and water intakes were measured every 24 h during the study. At 96 h after the first administration of the oral iron preparation, the duodenal and jejunal tissues were collected for analysis. Enterochromaffin cells were detected by immunohistochemical analysis.
Results: Administration of 3 mg/kg SF had no effect on anorexia but led to increased hyperplasia of enterochromaffin cells in the duodenum (p < 0.1). Administration of 30 mg/kg SF significantly decreased food and water intakes and significantly increased hyperplasia of enterochromaffin cells in the duodenum and jejunum. Alternatively, administration of 30 mg/kg FC had no significant effect on food and water intakes or hyperplasia of enterochromaffin cells.
Conclusion: The lower impact on the hyperplasia of enterochromaffin cells of FC compared to SF may contribute to the maintenance of rats' physical condition.
Keywords: Anorexia; Enterochromaffin cells; Ferric citrate hydrate; Sodium ferrous citrate; Tryptophan hydroxylase.
The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
[Consideration of the Characteristics of Oral Iron Preparations from the Viewpoint of the Mechanism of Nausea and Vomiting].Yakugaku Zasshi. 2023;143(7):599-606. doi: 10.1248/yakushi.23-00057. Yakugaku Zasshi. 2023. PMID: 37394455 Review. Japanese.
-
A Multicenter Single-Arm Study of Switching to Ferric Citrate Hydrate for Iron Deficiency Anemia in Patients Intolerant to Oral Iron: RIO-SWITCH.Adv Ther. 2025 May;42(5):2150-2167. doi: 10.1007/s12325-025-03123-9. Epub 2025 Mar 7. Adv Ther. 2025. PMID: 40053213 Free PMC article. Clinical Trial.
-
Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.Int J Hematol. 2021 Jul;114(1):8-17. doi: 10.1007/s12185-021-03123-9. Epub 2021 Mar 15. Int J Hematol. 2021. PMID: 33719027 Free PMC article. Clinical Trial.
-
Nitric oxide plays a critical role in methotrexate-induced hyperplasia of enterochromaffin cells containing 5-hydroxytryptamine in rat small intestine.J Pharmacol Sci. 2019 Sep;141(1):32-40. doi: 10.1016/j.jphs.2019.09.001. Epub 2019 Sep 10. J Pharmacol Sci. 2019. PMID: 31564550
-
Enterochromaffin cell hyperplasia in the gut: Factors, mechanism and therapeutic clues.Life Sci. 2019 Dec 15;239:116886. doi: 10.1016/j.lfs.2019.116886. Epub 2019 Oct 31. Life Sci. 2019. PMID: 31678286 Review.
Cited by
-
A Prospective Clinical Study of Ferric Citrate Hydrate for Chronic Heart Failure with Iron Deficiency Anemia.Life (Basel). 2025 Apr 3;15(4):598. doi: 10.3390/life15040598. Life (Basel). 2025. PMID: 40283153 Free PMC article.
References
-
- Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397((10270)):233–248. - PubMed
-
- Hoppe JO, Marcelli GM, Tainter ML. A review of the toxicity of iron compounds. Am J Med Sci. 1955;230:558–571. - PubMed
-
- Souza AI, Batista Filho MB, Bresani CC, Ferreira LOC, Figueiroa JN. Adherence and side effects of three ferrous sulfate treatment regimens on anemic pregnant women in clinical trials. Cad Saude Publica. 2009;25:1225–1233. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources